LY4405094

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Alzheimer DiseaseAmyloidHealthy VolunteersPlaque, Amyloid

Phase 1

A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

RecruitingNCT07787182

Eli Lilly and CompanyHealthy Volunteers, Alzheimer Disease, Amyloid +1

Start: 2025-10-14End: 2028-01-01Target: 68Updated: 2026-10-22

A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

RecruitingNCT07787169

Eli Lilly and CompanyAlzheimer Disease, Amyloid, Plaque, Amyloid +1

Start: 2026-09-09End: 2028-07-01Target: 179Updated: 2026-10-08